Literature DB >> 18557191

Investigation of bovine brucellosis in the Northeastern Turkey.

Mitat Sahin1, Oktay Genç, Ahmet Unver, Salih Otlu.   

Abstract

Bovine brucellosis, caused by Brucella abortus, is a significant problem for both public and animal health in Turkey. This study was conducted on the calving seasons between 2001 and 2006. A total of 626 serum samples of cattle obtained from 27 herds with a history of abortions was examined for Brucella antibodies by RBPT, SAT and ELISA. Of the cattle sera analysed, 221 (35.30%) and 206 (32.92%) and 247 (39.45%) were found to be positive by RBPT, SAT and ELISA, respectively. B. abortus was isolated from 48 (32.21%) of 149 lung samples and stomach contents of the aborted fetuses. Based on the biochemical tests and the agglutination tests with monospecific A and M antisera, only 3 of the isolates were found to be B. abortus biotype 1 and the remaining 45 were biotype 3. This study also revealed that the dominant biotype of B. abortus was biotype 3 in this region. The determination of the agents responsible for bovine brucellosis and serosurvey of this disease are expected to help better understanding of this zoonotic infection in this region and neighbouring countries.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18557191     DOI: 10.1007/s11250-007-9092-3

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  5 in total

Review 1.  Incidence and control of brucellosis in the Near East region.

Authors:  Mohamed Refai
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

2.  Brucellosis in the European Union and Norway at the turn of the twenty-first century.

Authors:  Jacques Godfroid; Annemarie Käsbohrer
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

3.  An overview of the epidemiology and epizootology of brucellosis in selected countries of Central and Southeast Europe.

Authors:  V Taleski; L Zerva; T Kantardjiev; Z Cvetnic; M Erski-Biljic; B Nikolovski; J Bosnjakovski; V Katalinic-Jankovic; A Panteliadou; S Stojkoski; T Kirandziski
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

4.  Human and animal brucellosis in Jordan between 1996 and 1998: a study.

Authors:  F K Al-Ani; S El-Qaderi; N Q Hailat; R Razziq; A M Al-Darraji
Journal:  Rev Sci Tech       Date:  2004-12       Impact factor: 1.181

5.  Seroprevalence of brucellosis in cattle and humans in the Akwapim-South district of Ghana: public health implications.

Authors:  D K Kubuafor; B Awumbila; B D Akanmori
Journal:  Acta Trop       Date:  2000-07-21       Impact factor: 3.112

  5 in total
  5 in total

Review 1.  Brucellosis - regionally emerging zoonotic disease?

Authors:  Mayada Gwida; Sascha Al Dahouk; Falk Melzer; Uwe Rösler; Heinrich Neubauer; Herbert Tomaso
Journal:  Croat Med J       Date:  2010-08       Impact factor: 1.351

2.  Rapid immunofiltration assay based on colloidal gold-protein G conjugate as an alternative screening test for bovine and ovine brucellosis.

Authors:  Oktay Genç; Ozlem Büyüktanır; Nevzat Yurdusev
Journal:  Trop Anim Health Prod       Date:  2011-11-21       Impact factor: 1.559

3.  Seroprevalence investigation of bovine brucellosis in Macenta and Yomou, Guinea.

Authors:  Seydou Sylla; Youssouf Sidimé; Yixue Sun; Sayon Doumbouya; Yanlong Cong
Journal:  Trop Anim Health Prod       Date:  2014-06-26       Impact factor: 1.559

4.  Seroprevalence of brucellosis in yaks (Poephagus grunniens) in India and evaluation of protective immunity to S19 vaccine.

Authors:  Samiran Bandyopadhyay; Debasis Sasmal; Tapan Kumar Dutta; Monoj Kumar Ghosh; Mihir Sarkar; Nihar Kanta Sasmal; Mohan Bhattacharya
Journal:  Trop Anim Health Prod       Date:  2008-09-02       Impact factor: 1.559

5.  Prevalence of brucellosis and infectious bovine rhinotracheitis in organized dairy farms in India.

Authors:  Bhavesh Trangadia; Samir Kumar Rana; Falguni Mukherjee; Villuppanoor Alwar Srinivasan
Journal:  Trop Anim Health Prod       Date:  2009-08-01       Impact factor: 1.559

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.